| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 785.10B | 764.81B | 736.56B | 692.16B | 611.63B | 550.34B |
| Gross Profit | 288.59B | 275.30B | 261.01B | 239.83B | 216.07B | 185.80B |
| EBITDA | 198.52B | 187.97B | 171.26B | 159.14B | 149.08B | 123.82B |
| Net Income | 101.67B | 93.76B | 79.64B | 76.31B | 71.44B | 52.87B |
Balance Sheet | ||||||
| Total Assets | 994.51B | 928.50B | 922.77B | 838.22B | 789.65B | 656.54B |
| Cash, Cash Equivalents and Short-Term Investments | 197.26B | 168.60B | 173.94B | 129.26B | 115.61B | 153.19B |
| Total Debt | 265.30B | 282.04B | 298.54B | 237.74B | 250.42B | 165.59B |
| Total Liabilities | 513.38B | 490.54B | 519.75B | 435.82B | 447.17B | 323.33B |
| Stockholders Equity | 477.38B | 434.04B | 399.53B | 399.01B | 339.36B | 330.50B |
Cash Flow | ||||||
| Free Cash Flow | 139.82B | 123.54B | 92.48B | 64.20B | 55.16B | 55.56B |
| Operating Cash Flow | 145.21B | 130.20B | 142.28B | 118.90B | 98.14B | 84.59B |
| Investing Cash Flow | -76.37B | -47.59B | -53.42B | -61.19B | -130.55B | -20.52B |
| Financing Cash Flow | -64.51B | -87.31B | -47.58B | -44.92B | -8.00B | -13.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $3.51T | 34.79 | 22.48% | 1.12% | 4.50% | 16.63% | |
74 Outperform | ¥7.92T | 17.20 | 15.02% | 0.67% | -8.58% | 83.16% | |
73 Outperform | ¥1.24T | 23.31 | ― | 1.39% | 4.95% | 9.54% | |
69 Neutral | ¥1.77T | 28.86 | ― | 1.48% | 42.98% | 48.88% | |
62 Neutral | ¥7.38T | 30.89 | 11.69% | 0.55% | 2.68% | 56.38% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ― | ― | ― | ― | 3.73% | 11.64% |
Nomura Research Institute, Ltd. (NRI) is a leading provider of consulting and IT solutions, operating primarily in the financial and industrial sectors, with a focus on digital transformation and innovation.
Nomura Research Institute reported a strong financial performance for the six months ending September 30, 2025, with a notable increase in revenue and profit compared to the previous year. The company achieved a 5.4% rise in revenue and a significant 20.1% growth in operating profit, reflecting its robust market positioning and effective operational strategies. This performance underscores the company’s ability to deliver value to its stakeholders and maintain a competitive edge in the industry.
The most recent analyst rating on (JP:4307) stock is a Hold with a Yen6205.00 price target. To see the full list of analyst forecasts on Nomura Research Institute stock, see the JP:4307 Stock Forecast page.